Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

January 13, 2023 | AI, Quant, Virtual, digital health 

Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.

- PMLiVE

The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

Small populations and even smaller sample sizes are a common problem when conducting healthcare market research, particularly within rare diseases. Could virtual patients help us to plug the gaps and determine how physicians might treat their patients in a clinical setting?

In the webcast, we demonstrate how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes. Using a series of real-life case studies, quantitative experts Richard Goosey and Will Tolley outline how we’ve been helping pharmaceutical companies to determine which patient attributes are driving treatment choices, which segments they should be targeting, and the likely demand for their product profiles using the latest technologies and advanced analytical techniques.

What are the takeaways?

  • Learn how virtual patients could help you to better understand treatment decisions
  • Discover how AI-powered conjoint can provide you with more actionable data
  • Find out how Research Partnership can help you to better predict what might happen using AI
  • Pick up practical tips for conducting conjoint in a range of small sample settings

Watch here

This content was provided by Research Partnership

Company Details

- PMLiVE

Research Partnership

Email
Website

 Latest Content from  Research Partnership 

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI

Authored by Paul Reed and Anabelle Gall

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.